The UNLOAD Trial Demonstrates Benefits of Ultrafiltration Compared with Diuretics

From CHF Solutions:

Presented as part of the ACC’s Late-Breaking Clinical Trials program, the study data show that hospitalized heart failure patients receiving ultrafiltration therapy as part of their care lost more weight and experienced greater net fluid loss than patients treated primarily with intravenous diuretics. At 90 days, the ultrafiltration group had significantly fewer days in the hospital, rehospitalizations for heart failure, unscheduled heart failure office visits and emergency room visits.

UNLOAD stands for Ultrafiltration versus IV Diuretics for Patients Hospitalized for Acute Decompensated Congestive Heart Failure. The press release is here.

Technorati Tags: unload trial, heart failure, cardiology, ultrafiltration, chf solutions, aquadex, aquapheresis, diuretics, nephrology